Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.
Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check22 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference4%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, with the latest update being version 2.10.5, which replaces version 2.10.3.SummaryDifference4%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has been updated from version v2.10.0 to v2.10.2.SummaryDifference0.3%
- Check87 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.